Division of Cardiovascular Medicine, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
Division of Cardiovascular Medicine, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):851-859. doi: 10.1016/j.jvsv.2019.11.014. Epub 2020 Jan 25.
Lower extremity lymphedema is frequently encountered in the vascular clinic. Established dogma purports that cancer is the most common cause of lower extremity lymphedema in Western countries, whereas chronic venous insufficiency (CVI) is often overlooked as a potential cause. Moreover, lymphedema is typically ascribed to a single cause, yet multiple causes can coexist.
A 3-year retrospective analysis was conducted of demographic and clinical characteristics of 440 eligible patients with lower extremity lymphedema who presented for lymphatic physiotherapy to a university medical center's cancer-based physical therapy department.
The four most common causes of lower extremity lymphedema were CVI (phlebolymphedema; 41.8%), cancer-related lymphedema (33.9%), primary lymphedema (12.5%), and lipedema with secondary lymphedema (11.8%). The collective cohort was more likely to be female (71.1%; P < .0001), to be white (78.9%; P < .0001), to demonstrate bilateral distribution (74.5%; P < .0001), and to have involvement of the left leg (bilateral, 69.1% [P < .0001]; unilateral, 58.9% [P = .0588]). Morbid obesity was pervasive (mean weight and body mass index, 115.8 kg and 40.2 kg/m, respectively) and significantly correlated with a higher International Society of Lymphology lymphedema stage (stage III mean weight and body mass index, 169.2 kg and 57.3 kg/m, respectively, vs stage II, 107.8 kg and 37.5 kg/m, respectively; P < .0001). Approximately one in three (35.7%) of the population sustained one or more episodes of cellulitis, but patients with stage III lymphedema had roughly twice the rate of soft tissue infection as patients with stage II, 61.7% vs 31.8%, respectively (P < .001). Multifactorial lymphedema was present in 25%. Approximately half of the patients with lipedema with secondary lymphedema (48.1%) or primary lymphedema (45.5%) had a superimposed cause of swelling that was usually CVI. Total knee arthroplasty was the most common cause of noncancer surgery-mediated worsening of pre-existing lymphedema.
In a large cohort of patients treated in a cancer-affiliated physical therapy department, CVI (phlebolymphedema), not cancer, was the predominant cause of lower extremity lymphedema. One in four patients had more than one cause of lymphedema. Notable clinical characteristics included a proclivity for female patients, bilateral distribution, left limb, cellulitis, and nearly universal morbid obesity.
下肢淋巴水肿在血管科经常遇到。既定的教条认为,癌症是西方国家下肢淋巴水肿的最常见原因,而慢性静脉功能不全(CVI)常常被忽视为潜在的原因。此外,淋巴水肿通常归因于单一原因,但多个原因可能同时存在。
对 440 名符合条件的下肢淋巴水肿患者进行了 3 年的回顾性分析,这些患者因淋巴水肿到大学医疗中心的癌症为基础的物理治疗部门接受淋巴生理治疗。
下肢淋巴水肿的四个最常见原因是 CVI(静脉淋巴水肿;41.8%)、癌症相关淋巴水肿(33.9%)、原发性淋巴水肿(12.5%)和脂性淋巴水肿伴继发性淋巴水肿(11.8%)。该队列更可能是女性(71.1%;P<0.0001),是白人(78.9%;P<0.0001),表现为双侧分布(74.5%;P<0.0001),且累及左腿(双侧,69.1%[P<0.0001];单侧,58.9%[P=0.0588])。病态肥胖普遍存在(平均体重和体重指数分别为 115.8 千克和 40.2 千克/平方米),且与更高的国际淋巴学会淋巴水肿分期显著相关(Ⅲ期平均体重和体重指数分别为 169.2 千克和 57.3 千克/平方米,而Ⅱ期分别为 107.8 千克和 37.5 千克/平方米;P<0.0001)。大约三分之一(35.7%)的人群发生过一次或多次蜂窝织炎,但Ⅲ期淋巴水肿患者的软组织感染率大约是Ⅱ期的两倍,分别为 61.7%和 31.8%(P<0.001)。多因素淋巴水肿占 25%。大约一半的脂性淋巴水肿伴继发性淋巴水肿(48.1%)或原发性淋巴水肿(45.5%)患者存在肿胀的叠加原因,通常是 CVI。全膝关节置换术是导致先前存在的淋巴水肿恶化的非癌症手术的最常见原因。
在一个癌症相关物理治疗部门治疗的大量患者队列中,CVI(静脉淋巴水肿)而不是癌症,是下肢淋巴水肿的主要原因。四分之一的患者有不止一个淋巴水肿的原因。显著的临床特征包括女性患者、双侧分布、左侧肢体、蜂窝织炎和普遍存在的病态肥胖。